Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples